The company's PrenaTest BioIT analysis software is now also cleared for use with a new methylation-specific qPCR assay for the detection of fetal trisomy 21.
CGI will provide target identification and biomarker discovery services for three cancer drugs that BeiGene is currently developing.
The Teva Pharmaceuticals subsidiary will have exclusive rights to distribute NantHealth's comprehensive molecular cancer test in Israel.
The company has identified markers of latent disease that it is now investigating to see if they could be useful for predicting progression to active infection.
The company is planning to work with up to 40 sites, with an initial goal of sequencing circulating cell-free DNA from 10,000 people.
In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.
After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.
Canada begins its search for a chief government science advisor, Nature News reports.
A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.